21-Hydroxylase Antibody (21-Ohab)
PCG is the FDA product code for 21-Hydroxylase Antibody (21-Ohab), a class II device type, regulated under 21 CFR 866.5660. FDA's definition for this code reads: "For semi-quantitative determination of antibodies to steroid 21-hydroxylase (21-OH) in human serum. The assay may be useful as an aid in the diagnosis of autoimmune adrenal disease, whether expressed as autoimmune Addison's disease (isolated) or Addison's disease as part of more complex autoimmune polyglandular...". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- PCG
- Device name
- 21-Hydroxylase Antibody (21-Ohab)
- FDA definition
- For semi-quantitative determination of antibodies to steroid 21-hydroxylase (21-OH) in human serum. The assay may be useful as an aid in the diagnosis of autoimmune adrenal disease, whether expressed as autoimmune Addison's disease (isolated) or Addison's disease as part of more complex autoimmune polyglandular syndrome (APS), type I or II. The assay result is to be used in conjunction with other clinical and laboratory findings and is not a substitute for functional testing required to diagnose adrenal insufficiency.
- Regulation
- 21 CFR 866.5660
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code PCG
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2012 | 1 |
| 2018 | 1 |
Applicants with the most clearances
Product code PCG| Applicant | Clearances |
|---|---|
| Kronus Market Development Associates, Inc. | 1 |
| Kronus, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
